Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0
作者：
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构：
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I：
10.2165/00003495-200666002-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：29 / 31
页数：2
相关论文
共 50 条
[31]   Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus [J].
B Mookerjee ;
V Altomonte ;
G Vogelsang .
Bone Marrow Transplantation, 1999, 24 :517-520
[32]   Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus [J].
Mookerjee, B ;
Altomonte, V ;
Vogelsang, G .
BONE MARROW TRANSPLANTATION, 1999, 24 (05) :517-520
[33]   Enteric-coated mycophenolate sodium for transplant immunosuppression [J].
Ingle, GR ;
Shah, T .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (21) :2252-2259
[34]   Review of the immunosuppressant enteric-coated mycophenolate sodium [J].
Budde, K ;
Glander, P ;
Diekmann, F ;
Waiser, J ;
Fritsche, L ;
Dragun, D ;
Neumayer, HH .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) :1333-1345
[35]   Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients [J].
Bolin, Paul ;
Tanriover, Bekir ;
Zibari, Gazi B. ;
Lynn, Melissa L. ;
Pirsch, John D. ;
Chan, Laurence ;
Cooper, Matthew ;
Langone, Anthony J. ;
Tomlanovich, Stephen J. .
TRANSPLANTATION, 2007, 84 (11) :1443-1451
[36]   Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis [J].
Ciancio, Gaetano ;
Gaynor, Jeffrey J. ;
Zarak, Alberto ;
Sageshima, Junichiro ;
Guerra, Giselle ;
Roth, David ;
Brown, Randolph ;
Kupin, Warren ;
Chen, Linda ;
Tueros, Lissett ;
Hanson, Lois ;
Ruiz, Phillip ;
Burke, George W., III .
TRANSPLANTATION, 2011, 91 (11) :1198-1205
[37]   Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium with the Concomitant Use of Proton Pump Inhibitors in Patients who Received Kidney Transplant [J].
Selcuk, Aysu ;
Pehlivanli, Aysel ;
Eyupoglu, Sahin ;
Ozcelikay, A. Tanju ;
Sengul, Sule .
TURKISH JOURNAL OF NEPHROLOGY, 2022, 31 (04) :348-354
[38]   Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients [J].
Graff, Jochen ;
Scheuermann, Ernst-Heinrich ;
Brandhorst, Gunnar ;
Oellerich, Michael ;
Gossmann, Jan .
THERAPEUTIC DRUG MONITORING, 2016, 38 (03) :388-392
[39]   Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil [J].
Lopez-Solis, Roberto ;
DeVera, Michael ;
Steel, Jennifer ;
Fedorek, Sheila ;
Sturdevant, Mark ;
Hughes, Christopher ;
Humar, Abhinav .
CLINICAL TRANSPLANTATION, 2014, 28 (07) :783-788
[40]   Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation [J].
Langone, Anthony ;
Shihab, Fuad ;
Pankewycz, Oleh ;
Doria, Cataldo ;
Wiland, Anne ;
McCague, Kevin ;
Chan, Laurence .
CLINICAL TRANSPLANTATION, 2014, 28 (09) :961-967
12345